We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Synthetic Biology Shows Promise to Cautious Public

By LabMedica International staff writers
Posted on 07 Oct 2010
Synthetic biology, defined as the design and construction of new biologic parts, devices, and systems or redesign of existing natural biologic systems for useful purposes, holds enormous potential to improve everything from medicine to energy production, with the global market projected to reach US$4.5 billion by 2015. More...


In regards to what the public knows about this emerging field, and what are their hopes and concerns, a new poll of 1,000 U.S. adults conducted by Hart Research Associates (Washington DC, USA) and the Synthetic Biology Project at the Woodrow Wilson Center (Washington DC, USA) found that two-thirds of Americans think that synthetic biology should move forward, but with more research to study its possible effects on humans and the environment, while one-third support a ban until we better understand its implications and risks. More than half of Americans believe the federal government should be involved in regulating synthetic biology.

"The survey clearly shows that much more attention needs to be paid to addressing biosafety and biosecurity risks,” said Dr. David Rejeski, director of the Synthetic Biology Project. "In addition, government and industry need to engage the public about the science and its applications, benefits, and risks.”

The poll findings reveal that the proportion of adults who reported they have heard a lot or some about synthetic biology has almost tripled in three years, (from 9 - 26%). By comparison, self-reported awareness of nanotechnology increased from 24 - 34% during the same three-year period.

Although the public supports continued research in the area of synthetic biology, it also harbors concerns, including 27% who have security concerns (i.e., that the science will be used to make harmful things), 25% who have moral concerns; and a similar amount who worry about negative health consequences for humans. A smaller portion, 13%, worries about possible damage to the environment.

"The survey shows that attitudes about synthetic biology are not clear-cut and that its application is an important factor in shaping public attitudes towards it,” said Geoff Garin, president of Hart Research. Six in 10 respondents support the use of synthetic biology to produce a flu vaccine. In contrast, three-fourths of those surveyed have concerns about its use to accelerate the growth of livestock to increase food production. Among those for whom moral issues are the top concern, the majority views both applications in a negative light.

The findings derive from a nationwide telephone survey of 1,000 adults and has a margin of error of ±3.1 percentage points. This is the fifth year that Hart Research Associates has conducted a survey to gauge public opinion about nanotechnology and/or synthetic biology for the Woodrow Wilson International Center for Scholars.

The Woodrow Wilson International Center for Scholars of the Smithsonian Institution was established by Congress in 1968. It is a nonpartisan institution, supported by public and private funds and engaged in the study of national and world affairs.

Related Links:
Hart Research Associates
Synthetic Biology Project at the Woodrow Wilson Center



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automated Urinalysis Solution
UN-9000
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.